糖蛋白Ib
血小板
血小板膜糖蛋白
糖蛋白
血小板糖蛋白GPIb-IX复合物
生物化学
瑞斯托西汀
血小板活化
伯纳德-苏利尔综合征
化学
凝血酶
医学
细胞生物学
功能(生物学)
血小板聚集
二磷酸腺苷
止血
生物物理学
内科学
作者
G.A. Jamieson,Tadayoshi Okumura,M Hasitz
出处
期刊:Thrombosis and Haemostasis
[Georg Thieme Verlag KG]
日期:1979-01-01
被引量:14
标识
DOI:10.1055/s-0038-1657074
摘要
Summary Present knowledge of the structure and function of platelet glycocalicin is reviewed. Glycocalicin (M,. 150,000) is a glycoprotein component of the outer surface of intact platelets which is released in soluble form following platelet homogenization. Glycocalicin has been purified and shown to inhibit platelet aggregation induced by thrombin or by ristocetin. Thrombin binding activity is associated with the peptide “tail” of the molecule (Mr 45,000), the macroglycopeptide portion (Mr 120,000) being without effect. Glycocalicin and membrane-bound glycoprotein I have been shown to be functionally and immunologically identical. Studies with platelets modified by chymotrypsin, and with platelets from patients with Bemard-Soulier disease and an ill-defined bleeding abnormality show that the amount of thrombin bound is proportional to the total amount of glycocalicin and glycoprotein I present. These results support the concept of a single class of binding site for thrombin in platelets.
科研通智能强力驱动
Strongly Powered by AbleSci AI